Journal Mobile Options
Table of Contents
Vol. 25, No. 1, 2009
Issue release date: August 2009
Fetal Diagn Ther 2009;25:15–20
(DOI:10.1159/000188056)

Sacrococcygeal Teratomas: Prenatal Surveillance, Growth and Pregnancy Outcome

Wilson R.D. · Hedrick H. · Flake A.W. · Johnson M.P. · Bebbington M.W. · Mann S. · Rychik J. · Liechty K. · Adzick N.S.
Fetal Heart Program, The Center for Fetal Diagnosis and Treatment, The Children’s Hospital of Philadelphia, and Departments of Surgery, Obstetrics/Gynecology, and Pediatrics, University of Pennsylvania, School of Medicine, Philadelphia, Pa., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Objective: Prenatal surveillance and growth characteristics are evaluated in a cohort of fetuses with sacrococcygeal teratomas (SCT) as part of risk assessment. Methods: Retrospective review of 23 fetuses with SCT: prenatal diagnosis, surveillance, delivery, and early postnatal outcome are reported. Results: Cardiac output failure physiology requires serial evaluation. The size of the SCT determines obstetrical risks and mode of delivery. An SCT growth rate approaching >150 cm3 per week may be associated with increased perinatal mortality risks. Maternal morbidity is related mainly to polyhydramnios and preterm labor. Conclusions: Perinatal mortality is approximately 43%. Maternal-fetal surgery for fetal physiologic deterioration is not frequent, but serial surveillance is required to minimize fetal morbidity/mortality and maternal morbidity. Rapid SCT growth rates may be associated with increased risk of perinatal mortality.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Adzick NS, Kitano Y: Fetal surgery for lung lesions, congenital diaphragmatic hernia, and acrococcygeal teratoma. Semin Pediatr Surg 2003;12:154–167.
  2. Hedrick HL, Flake TM, Crombleholme TM, Howell LJ, Johnson MP, Wilson RD, Adzick NS: Sacrococcygeal teratoma: prenatal assessment, fetal intervention, and outcome. J Ped Surg 2004;39:430–438.
  3. Firth HV, Hurst JA, Hall JG (eds): Oxford Desk Reference. Clinical Genetics. Oxford, Oxford University Press, 2005, p 576.
  4. Sanders RC, Blackmon LR, Hogge WA, Spevak P, Wulfsberg EA: Sacrococcygeal Teratoma; in Sanders RC (ed): Structural Fetal Abnormalities: The Total Picture, ed 2. St. Louis, Mosby, 2002, pp 171–173.
  5. Bianchi DW, Crombleholme TM, D’Alton ME: Sacrococcygeal teratoma; in Bianchi DW, Crombleholme TM, D’Alton ME (eds): Fetology: Diagnosis and Management of the Fetal Patient. New York, McGraw-Hill, 2000, pp 867–877.
  6. Romero R, Pilu G, Jeanty P, Ghidini A, Hobbins JC: Sacrococcygeal teratoma; in Romero R, Pilu G, Jeanty P, Ghidini A, Hobbins JC (eds): Prenatal Diagnosis of Congenital Anomalies. East Norwalk, Appleton & Lange, 1988, pp 427–431.
  7. Benacerraf BR: Teratoma; in Benacerraf BR (ed): Ultrasound of Fetal Syndromes. Philadelphia, Churchill-Livingstone, 1998, pp 351–356.
  8. Woodward PJ, Kennedy A, Sohaey R, Byrne JLB, Oh KY, Puchalski MD: Sacrococcygeal teratoma; in Woodward PJ, Kennedy A, Sohaey R, Byrne JLB, Oh KY, Puchalski MD (eds): Diagnostic Imaging Obstetrics. Salt Lake City, Amirsys Inc, 2005, pp 22–25.
  9. Danzer E, Hubbard A, Hedrick H, Johnson MP, Wilson RD, Howell L, Flake A, Adzick N: Diagnosis and characterization of fetal sacrococcygeal teratoma with prenatal MRI. AJR Am J Roentgenol 2006;187:W350–W356.
  10. Adzick NS, Crombleholme TM, Morgan MA, et al: A rapidly growing fetal teratoma. Lancet 1997;349:538.
  11. Sy ED, Lee H, Ball R, et al: Spontaneous rupture of fetal sacrococcygeal teratoma. Fetal Diagn Ther 2006;21:424–427.
  12. Batukan C, Ozgun Tuncay M, Basbug M, Caglayan O, Dundar M, Murat N: Sacrococcygeal teratoma in a fetus with prenatally diagnosed partial trisomy 10q (10q24.3→qter) and partial monosomy 17p (p13.3→pter). Prenat Diagn 2007;27:365–368.
  13. Altman RP, Randolph JG, Lilly JR: Sacrococcygeal teratoma: American Academy of Pediatrics Surgical Section Survey – 1973. J Pediatr Surg 1974;9:389–398.
  14. Neubert S, Trautmann K, Tanner B, Steiner E, Linke F: Sonographic prognostic factors in prenatal diagnosis of SCT. Fetal Diagn Ther 2004;19:319–326.
  15. Olutoye OO, Johnson MP, Coleman BG, Crombleholme TM, Adzick NS, Flake AW: Abnormal umbilical cord Doppler sonograms may predict impending demise in fetuses with sacrococcygeal teratoma. Fetal Diagn Ther 2004;19:35–39.
  16. Benachi A, Durin L, Vasseur Maurer S, Aubry MC, Parat S, Herlicoviez M, Nihout-Fekete C, Dumez Y, Dommergues M: Prenatally diagnosed sacrococcygeal teratoma: a prognostic classification. J Pediatr Surg 2006;41:1517–1521.
  17. Makin EC, Hyett J, Ade-Ajayi N, Patel S, Nicolaides K, Davenport M: Outcome of antenatally diagnosed sacrococcygeal teratomas: single-center experience (1993–2004). J Pediatr Surg 2006;41:388–393.
  18. den Otter SCM, de Mol AC, Eggink AJ, van Heijst AFJ, de Bruijn D, Wijnen RMH: Major sacrococcygeal teratoma in an extreme premature infant: a multidisciplinary approach. Fetal Diagn Ther 2008;23:41–45.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50